Luke Evans MP: written questions
4 Jul 2025–3 Jul 2026
How these years work
Our reporting years run from 4 July to 3 July, starting with the 2024 general election. They are not official parliamentary sessions. Office costs keep IPSA’s April–March financial years. Records may cover only part of a year; a missing record does not mean no work was done.
Written questions: dates and coverage
- Source checked
- 21 Nov 2026
- Last successful import
- 21 Nov 2026
- Records dated through
- 20 Nov 2026
- Selected period
- Reporting year 2: 4 Jul 2025 to 3 Jul 2026
- Completeness
- Published snapshot: 25,747 records in the source window 23 Aug 2026 to 21 Nov 2026. The published snapshot covers its stated source window. Answers and corrections can appear later; no indexed answer does not prove that none exists.
Understand written questions, dates and answers.
Read what this MP said, asked and contributed in Parliament.
225 published records · newest first.
Written questions
Steroid Drugs: MenDepartment of Health and Social CareTabled 30 Jun 2026AnsweredUIN 14443More
Question: To ask the Secretary of State for Health and Social Care, pursuant to WPQ 9089 answered on 19 June 2026 about Steroid Drugs: Young People, if he will hold discussions with [i] local and national health bodies, [ii] academics and [iii] the Men's Health Str
Answer: We are committed to working in partnership with men, academics, stakeholders, research funders, employers, service providers, and important sectors such as media and sport to implement the Men’s Health Strategy. This includes our Men’s Health Academic Net...
Answered 13 Jul 2026
Original Parliament recordGeneral Practitioners: Hinckley and BosworthDepartment of Health and Social CareTabled 30 Jun 2026AnsweredUIN 14440More
Question: To ask the Secretary of State for Health and Social Care, to ask the Secretary of State for Health and Social Care, with reference to the Prime Minister's oral contribution of 29 April 2026, official report, Volume 784, column 895, what is the evidential
Answer: 82 general practitioners have been recruited through the Additional Roles Reimbursement Scheme (ARRS) in the Leicester, Leicestershire and Rutland Integrated Care Board since October 2024. The data can be found in table 1 of the March 2026 ARRS claims fil...
Answered 6 Jul 2026
Original Parliament recordSteroid DrugsDepartment of Health and Social CareTabled 30 Jun 2026AnsweredUIN 14439More
Question: To ask the Secretary of State for Health and Social Care, if he will hold discussions with (a) local and national health bodies, (b) academics and (c) the Men's Health Strategy Stakeholder Group on the issues surrounding Anabolic Steroids, IPEDs and SARMS
Answer: We are committed to working in partnership with men, academics, stakeholders, research funders, employers, service providers, and important sectors such as media and sport to implement the Men’s Health Strategy. This includes our Men’s Health Academic Net...
Answered 13 Jul 2026
Original Parliament recordLeukaemia: DiagnosisDepartment of Health and Social CareTabled 30 Jun 2026AnsweredUIN 14438More
Question: To ask the Secretary of State for Health and Social Care, what recent steps he has taken to support the national rollout of the Leukaemia Best Practice Timed Pathway.
Answer: NHS England is supporting development of a suspected haematology cancer timed diagnostic pathway, which is being developed by Leukaemia UK, Lymphoma Action, and Myeloma UK.Publication of this pathway document is expected later this year.
Answered 15 Jul 2026
Original Parliament recordGeneral Practitioners: FinanceDepartment of Health and Social CareTabled 18 Jun 2026AnsweredUIN 11195More
Question: To ask the Secretary of State for Health and Social Care, what the planned timetable is for the complete conclusion of the review of the Carr-Hill formula, and the publication of its findings.
Answer: Phase 1 of the Carr-Hill review concluded in May 2026. The report and recommendations are currently with the Department for consideration. The review’s findings and recommendations will be published in due course by the National Institute for Health and C...
Answered 30 Jun 2026
Original Parliament recordGeneral Practitioners: FinanceDepartment of Health and Social CareTabled 18 Jun 2026AnsweredUIN 11194More
Question: To ask the Secretary of State for Health and Social Care, when he expects the National Institute for Health and Care Research to publish findings from phase one of the Carr-Hill review.
Answer: Phase 1 of the Carr-Hill review concluded in May 2026. The report and recommendations are currently with the Department for consideration. The review’s findings and recommendations will be published in due course by the National Institute for Health and C...
Answered 30 Jun 2026
Original Parliament recordSteroid Drugs: Young PeopleDepartment of Health and Social CareTabled 11 Jun 2026AnsweredUIN 9089More
Question: To ask the Secretary of State for Health and Social Care, pursuant to WPQs 2849, 2850 and 2851 answered on 9 June 2026 about Steroid Drugs: Young People, if he will ensure that issues surrounding Anabolic Steroids, IPEDs and SARMs are included in work to
Answer: Since the strategy’s launch, significant work and focus has been on implementing the commitments set out in the Men’s Health Strategy. For example, our landmark partnership with the Premier League will bring together football clubs and government to impro...
Answered 19 Jun 2026
Original Parliament recordSteroid Drugs: Young PeopleDepartment of Health and Social CareTabled 11 Jun 2026AnsweredUIN 9088More
Question: To ask the Secretary of State for Health and Social Care, pursuant to WPQs 2849, 2850 and 2851 answered on 9 June 2026 about Steroid Drugs: Young People, if he will have discussions with the Secretary of State for Science, Innovation and Technology on con
Answer: Following the national consultation, Growing up in the Online World, the Government is banning social media companies from offering their services to children under 16 years old. We will take the same approach as Australia. This will capture user-to-user ...
Answered 8 Jul 2026
Original Parliament recordSteroid Drugs: Young PeopleDepartment of Health and Social CareTabled 11 Jun 2026AnsweredUIN 9087More
Question: To ask the Secretary of State for Health and Social Care, pursuant to WPQs 2849, 2850 and 2851 answered on 9 June 2026 about Steroid Drugs: Young People, if he will have discussions with UK Anti Doping on the findings of their 2026 Clean Sport Survey on t
Answer: The Department for Culture, Media and Sport are responsible for anti-doping in sport.In November 2025, the Department of Health and Social Care launched England’s first ever Men’s Health Strategy, which sets out a bold vision to improve the health and wel...
Answered 17 Jul 2026
Original Parliament recordHealth Services: StandardsDepartment of Health and Social CareTabled 4 Jun 2026AnsweredUIN 6794More
Question: To ask the Secretary of State for Health and Social Care, what data is held by NHS England on the use and impact of minimum waiting time policies across Integrated Care Boards; and whether this information is collected centrally.
Answer: There is no formal national policy supporting minimum waits in the National Health Service. However, the NHS Standard Contract allows local commissioners to set activity planning assumptions to plan demand, capacity, and expenditure.It is important to not...
Answered 22 Jun 2026
Original Parliament recordHealth Services: StandardsDepartment of Health and Social CareTabled 4 Jun 2026AnsweredUIN 6793More
Question: To ask the Secretary of State for Health and Social Care, what assessment his Department has made of the compatibility of minimum waiting time policies with the NHS Constitution for England, including patients’ rights to access services within maximum wai
Answer: There is no formal national policy supporting minimum waits in the National Health Service. However, the NHS Standard Contract allows local commissioners to set activity planning assumptions to plan demand, capacity, and expenditure.It is important to not...
Answered 22 Jun 2026
Original Parliament recordHealth Services: StandardsDepartment of Health and Social CareTabled 4 Jun 2026AnsweredUIN 6792More
Question: To ask the Secretary of State for Health and Social Care, what guidance NHS England has issued to Integrated Care Boards on the use of minimum waiting times; and whether prior approval is required before such policies are implemented.
Answer: There is no formal national policy supporting minimum waits in the National Health Service. However, the NHS Standard Contract allows local commissioners to set activity planning assumptions to plan demand, capacity, and expenditure.It is important to not...
Answered 22 Jun 2026
Original Parliament recordHealth Services: StandardsDepartment of Health and Social CareTabled 4 Jun 2026AnsweredUIN 6791More
Question: To ask the Secretary of State for Health and Social Care, for which procedures, treatments or clinical pathways minimum waiting times have been applied by Integrated Care Boards; and what criteria are used to determine their application.
Answer: There is no formal national policy supporting minimum waits in the National Health Service. However, the NHS Standard Contract allows local commissioners to set activity planning assumptions to plan demand, capacity, and expenditure.It is important to not...
Answered 22 Jun 2026
Original Parliament recordHealth Services: StandardsDepartment of Health and Social CareTabled 4 Jun 2026AnsweredUIN 6790More
Question: To ask the Secretary of State for Health and Social Care, if he will list the integrated care boards that have implemented policies involving minimum waiting times for NHS treatment.
Answer: There is no formal national policy supporting minimum waits in the National Health Service. However, the NHS Standard Contract allows local commissioners to set activity planning assumptions to plan demand, capacity, and expenditure.It is important to not...
Answered 22 Jun 2026
Original Parliament recordGeneral Practitioners: ContractsDepartment of Health and Social CareTabled 3 Jun 2026AnsweredUIN 6695More
Question: To ask the Secretary of State for Health and Social Care, whether his Department has held discussions with the General Medical Council on the potential impact of the policy on GPs’ use of advice and guidance on (a) GP indemnity and (b) patient safety.
Answer: The Department and NHS England considered the potential impacts of expanding Advice and Guidance (A&G) as part of the policy development process, including through clinical input, established governance arrangements, and equalities considerations. A&a...
Answered 18 Jun 2026
Original Parliament recordGeneral Practitioners: ContractsDepartment of Health and Social CareTabled 3 Jun 2026AnsweredUIN 6694More
Question: To ask the Secretary of State for Health and Social Care, whether his Department has held discussions with the Care Quality Commission on the potential impact of the policy on GPs’ use of advice and guidance on (a) GP indemnity and (b) patient safety.
Answer: The Department and NHS England considered the potential impacts of expanding Advice and Guidance (A&G) as part of the policy development process, including through clinical input, established governance arrangements, and equalities considerations. A&a...
Answered 18 Jun 2026
Original Parliament recordGeneral Practitioners: ContractsDepartment of Health and Social CareTabled 3 Jun 2026AnsweredUIN 6693More
Question: To ask the Secretary of State for Health and Social Care, whether his Department has made an assessment of the impact on patient safety of his policy on GPs’ use of advice and guidance.
Answer: The Department and NHS England considered the potential impacts of expanding Advice and Guidance (A&G) as part of the policy development process, including through clinical input, established governance arrangements, and equalities considerations. A&a...
Answered 18 Jun 2026
Original Parliament recordDrugs: VATDepartment of Health and Social CareTabled 3 Jun 2026AnsweredUIN 6626More
Question: To ask the Secretary of State for Health and Social Care, what assessment he has made of the potential risk that pharmaceutical companies could withdraw compassionate access programmes due to VAT-related financial pressures.
Answer: The Government recognises the important role that compassionate and expanded access programmes can play in enabling patients, particularly those with serious or rare conditions, to access innovative medicines outside routine commissioning arrangements.VAT...
Answered 10 Jun 2026
Original Parliament recordNHS: DrugsDepartment of Health and Social CareTabled 2 Jun 2026AnsweredUIN 6017More
Question: To ask the Secretary of State for Health and Social Care, what estimate he has made of the number of compassionate or expanded access schemes affected by VAT-related costs, including any schemes that have been withdrawn.
Answer: The Department is working closely with HM Treasury and HM Revenue and Customs to explore options in relation to the VAT treatment of medicines supplied free of charge to the National Health Service, including those provided through compassionate use and e...
Answered 22 Jun 2026
Original Parliament recordNHS: DrugsDepartment of Health and Social CareTabled 2 Jun 2026AnsweredUIN 6016More
Question: To ask the Secretary of State for Health and Social Care, whether he has held recent discussions with colleagues in the Treasury on the pause in applying VAT to compassionate medicines programmes.
Answer: The Department is working closely with HM Treasury and HM Revenue and Customs to explore options in relation to the VAT treatment of medicines supplied free of charge to the National Health Service, including those provided through compassionate use and e...
Answered 22 Jun 2026
Original Parliament recordNHS: DrugsDepartment of Health and Social CareTabled 2 Jun 2026AnsweredUIN 6015More
Question: To ask the Secretary of State for Health and Social Care, what recent discussions he has had with the Chancellor of the Exchequer on exempting compassionate medicines programmes from VAT.
Answer: The Department is working closely with HM Treasury and HM Revenue and Customs to explore options in relation to the VAT treatment of medicines supplied free of charge to the National Health Service, including those provided through compassionate use and e...
Answered 22 Jun 2026
Original Parliament recordCancer: ChildrenDepartment of Health and Social CareTabled 2 Jun 2026AnsweredUIN 6014More
Question: To ask the Secretary of State for Health and Social Care, what assessment he has made of the impact on children with relapsed or rare cancers of reduced availability of compassionate access to innovative therapies.
Answer: The Government recognises the importance of enabling timely access to innovative medicines, particularly for patients with rare and life‑threatening conditions, including children with relapsed or rare cancers.The availability of medicines through company...
Answered 22 Jun 2026
Original Parliament recordNHS: DrugsDepartment of Health and Social CareTabled 2 Jun 2026AnsweredUIN 6013More
Question: To ask the Secretary of State for Health and Social Care, what steps he is taking to provide patients with continuity of access to compassionate medicines following the withdrawal by some pharmaceutical companies of early access scheme medicines.
Answer: The Government recognises the importance of enabling timely access to innovative medicines, particularly for patients with rare and life‑threatening conditions, including children with relapsed or rare cancers.The availability of medicines through company...
Answered 22 Jun 2026
Original Parliament recordSuicide: MenDepartment of Health and Social CareTabled 29 May 2026AnsweredUIN 4625More
Question: To ask the Secretary of State for Health and Social Care, whether steps have been taken to ensure neighbourhood health delivers effective suicide prevention support for middle aged men.
Answer: The Government recognises the importance of effective suicide prevention support for middle-aged men, who remain disproportionately affected by suicide.The Government’s 10-Year Health Plan sets out ambitious reforms to shift healthcare from hospital to co...
Answered 17 Jun 2026
Original Parliament recordSuicide: MenDepartment of Health and Social CareTabled 29 May 2026AnsweredUIN 4624More
Question: To ask the Secretary of State for Health and Social Care, what steps his Department is taking to ensure GPs are adequately trained and equipped to identify and respond to men at risk of suicide.
Answer: Our first ever Men’s Health Strategy, launched on 19 November 2025, announced the Suicide Prevention Support Pathfinders programme which will invest up to £3.6 million over three years in areas of England where middle-aged men face the greatest risk of su...
Answered 24 Jun 2026
Original Parliament record
Explore activity by topic or department
Written questions by answering department
4 Jul 2025–3 Jul 2026. One record per UIN and tabled date; the named department is not a measure of answer quality.
View as listWhat this shows and doesn't show
Published records only — not a full account of an MP’s work. How we work →